Prior studies have suggested that downregulation of the cGAS‐STING axis is an immune escape strategy exploited by tumor cells (Song et al, 2017, Xia et al, 2016), despite evidence that high expression of cGAS and/or STING predicts poor outcome for cancer patients (An et al, 2019). This evidence concerns the gene CGAS and cancer.